Retrospective evaluation of intravenous fentanyl patient-controlled analgesia during labor

Yuki Hosokawa, Kei Miyakoshi, Hiroshi Morisaki, Mamoru Tanaka, Itsuo Nakatsuka, Yasunori Yoshimura, Saori Hashiguchi, Junzo Takeda

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose Because the safety of intravenous fentanyl patient-controlled analgesia (iv-PCA) administered during labor remains unclear, we retrospectively examined the labor records from January 2005 to December 2007 in our institution, with a focus on both maternal and neonatal outcomes, as compared to no analgesia. Methods Parturients over 35 weeks of gestational age who received fentanyl iv-PCA (iv-PCA group) or no analgesia (control group) during labor were enrolled. The former group received iv-PCA through a pump programmed to give a loading dose of 0.05 mg fentanyl, followed by bolus injection of 0.02 mg fentanyl, with a lock-out interval of 5 min. This analgesia was initiated at the parturient's request and was discontinued before the second stage of labor, to ensure neonatal safety. During labor, both maternal and fetal heart rates, maternal pulse oximeter oxygen saturation (SpO 2), respiratory rate, and sedation and nausea scores were continuously monitored, and the neonatal outcomes including umbilical arterial pH, Apgar scores, and other parameters were recorded. Results The data of 129 of the 143 parturients who received fentanyl iv-PCA were analyzed, while 697 parturients delivered without any analgesia during the 3-year study period. While iv-PCA prolonged the duration of labor and increased oxytocin use, no obvious maternal or neonatal complications of fentanyl use were recorded. Except for the significantly lower rate of emergency cesarean section in the iv-PCA group, both the maternal and neonatal outcomes were comparable between the groups. Conclusions As compared to no analgesia, fentanyl iv-PCA appears to be safe and clinically acceptable as analgesia during labor, particularly in nulliparous women.

Original languageEnglish
Pages (from-to)219-224
Number of pages6
JournalJournal of Anesthesia
Volume26
Issue number2
DOIs
Publication statusPublished - 2012 Apr

Fingerprint

Patient-Controlled Analgesia
Fentanyl
Analgesia
Mothers
Parturition
Second Labor Stage
Safety
Umbilicus
Fetal Heart Rate
Apgar Score
Oxytocin
Respiratory Rate
Cesarean Section
Nausea
Gestational Age

Keywords

  • Fentanyl
  • Intravenous patient-controlled analgesia
  • Labor analgesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Retrospective evaluation of intravenous fentanyl patient-controlled analgesia during labor. / Hosokawa, Yuki; Miyakoshi, Kei; Morisaki, Hiroshi; Tanaka, Mamoru; Nakatsuka, Itsuo; Yoshimura, Yasunori; Hashiguchi, Saori; Takeda, Junzo.

In: Journal of Anesthesia, Vol. 26, No. 2, 04.2012, p. 219-224.

Research output: Contribution to journalArticle

@article{1150ef100a2b4252a36d671486fa0ddb,
title = "Retrospective evaluation of intravenous fentanyl patient-controlled analgesia during labor",
abstract = "Purpose Because the safety of intravenous fentanyl patient-controlled analgesia (iv-PCA) administered during labor remains unclear, we retrospectively examined the labor records from January 2005 to December 2007 in our institution, with a focus on both maternal and neonatal outcomes, as compared to no analgesia. Methods Parturients over 35 weeks of gestational age who received fentanyl iv-PCA (iv-PCA group) or no analgesia (control group) during labor were enrolled. The former group received iv-PCA through a pump programmed to give a loading dose of 0.05 mg fentanyl, followed by bolus injection of 0.02 mg fentanyl, with a lock-out interval of 5 min. This analgesia was initiated at the parturient's request and was discontinued before the second stage of labor, to ensure neonatal safety. During labor, both maternal and fetal heart rates, maternal pulse oximeter oxygen saturation (SpO 2), respiratory rate, and sedation and nausea scores were continuously monitored, and the neonatal outcomes including umbilical arterial pH, Apgar scores, and other parameters were recorded. Results The data of 129 of the 143 parturients who received fentanyl iv-PCA were analyzed, while 697 parturients delivered without any analgesia during the 3-year study period. While iv-PCA prolonged the duration of labor and increased oxytocin use, no obvious maternal or neonatal complications of fentanyl use were recorded. Except for the significantly lower rate of emergency cesarean section in the iv-PCA group, both the maternal and neonatal outcomes were comparable between the groups. Conclusions As compared to no analgesia, fentanyl iv-PCA appears to be safe and clinically acceptable as analgesia during labor, particularly in nulliparous women.",
keywords = "Fentanyl, Intravenous patient-controlled analgesia, Labor analgesia",
author = "Yuki Hosokawa and Kei Miyakoshi and Hiroshi Morisaki and Mamoru Tanaka and Itsuo Nakatsuka and Yasunori Yoshimura and Saori Hashiguchi and Junzo Takeda",
year = "2012",
month = "4",
doi = "10.1007/s00540-011-1292-3",
language = "English",
volume = "26",
pages = "219--224",
journal = "Journal of Anesthesia",
issn = "0913-8668",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Retrospective evaluation of intravenous fentanyl patient-controlled analgesia during labor

AU - Hosokawa, Yuki

AU - Miyakoshi, Kei

AU - Morisaki, Hiroshi

AU - Tanaka, Mamoru

AU - Nakatsuka, Itsuo

AU - Yoshimura, Yasunori

AU - Hashiguchi, Saori

AU - Takeda, Junzo

PY - 2012/4

Y1 - 2012/4

N2 - Purpose Because the safety of intravenous fentanyl patient-controlled analgesia (iv-PCA) administered during labor remains unclear, we retrospectively examined the labor records from January 2005 to December 2007 in our institution, with a focus on both maternal and neonatal outcomes, as compared to no analgesia. Methods Parturients over 35 weeks of gestational age who received fentanyl iv-PCA (iv-PCA group) or no analgesia (control group) during labor were enrolled. The former group received iv-PCA through a pump programmed to give a loading dose of 0.05 mg fentanyl, followed by bolus injection of 0.02 mg fentanyl, with a lock-out interval of 5 min. This analgesia was initiated at the parturient's request and was discontinued before the second stage of labor, to ensure neonatal safety. During labor, both maternal and fetal heart rates, maternal pulse oximeter oxygen saturation (SpO 2), respiratory rate, and sedation and nausea scores were continuously monitored, and the neonatal outcomes including umbilical arterial pH, Apgar scores, and other parameters were recorded. Results The data of 129 of the 143 parturients who received fentanyl iv-PCA were analyzed, while 697 parturients delivered without any analgesia during the 3-year study period. While iv-PCA prolonged the duration of labor and increased oxytocin use, no obvious maternal or neonatal complications of fentanyl use were recorded. Except for the significantly lower rate of emergency cesarean section in the iv-PCA group, both the maternal and neonatal outcomes were comparable between the groups. Conclusions As compared to no analgesia, fentanyl iv-PCA appears to be safe and clinically acceptable as analgesia during labor, particularly in nulliparous women.

AB - Purpose Because the safety of intravenous fentanyl patient-controlled analgesia (iv-PCA) administered during labor remains unclear, we retrospectively examined the labor records from January 2005 to December 2007 in our institution, with a focus on both maternal and neonatal outcomes, as compared to no analgesia. Methods Parturients over 35 weeks of gestational age who received fentanyl iv-PCA (iv-PCA group) or no analgesia (control group) during labor were enrolled. The former group received iv-PCA through a pump programmed to give a loading dose of 0.05 mg fentanyl, followed by bolus injection of 0.02 mg fentanyl, with a lock-out interval of 5 min. This analgesia was initiated at the parturient's request and was discontinued before the second stage of labor, to ensure neonatal safety. During labor, both maternal and fetal heart rates, maternal pulse oximeter oxygen saturation (SpO 2), respiratory rate, and sedation and nausea scores were continuously monitored, and the neonatal outcomes including umbilical arterial pH, Apgar scores, and other parameters were recorded. Results The data of 129 of the 143 parturients who received fentanyl iv-PCA were analyzed, while 697 parturients delivered without any analgesia during the 3-year study period. While iv-PCA prolonged the duration of labor and increased oxytocin use, no obvious maternal or neonatal complications of fentanyl use were recorded. Except for the significantly lower rate of emergency cesarean section in the iv-PCA group, both the maternal and neonatal outcomes were comparable between the groups. Conclusions As compared to no analgesia, fentanyl iv-PCA appears to be safe and clinically acceptable as analgesia during labor, particularly in nulliparous women.

KW - Fentanyl

KW - Intravenous patient-controlled analgesia

KW - Labor analgesia

UR - http://www.scopus.com/inward/record.url?scp=84863226805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863226805&partnerID=8YFLogxK

U2 - 10.1007/s00540-011-1292-3

DO - 10.1007/s00540-011-1292-3

M3 - Article

C2 - 22120170

AN - SCOPUS:84863226805

VL - 26

SP - 219

EP - 224

JO - Journal of Anesthesia

JF - Journal of Anesthesia

SN - 0913-8668

IS - 2

ER -